Drug Trial Radar · NCT03107377
Phase 2B/3 Double-blinded Placebo-controlled
Last checked: Nov 20, 2026Latest source record: Aug 12, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
860
Actual
Start
Nov 3, 2017
Primary completion
Aug 22, 2019
Study completion Aug 22, 2019
Sponsor
- Lead sponsor
- Evofem Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Clinical Research Management, Inc.
- First posted
- Apr 11, 2017
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Phase 2B double-blind placebo-controlled efficacy trial of EVO100 (previously known as Amphora ® Gel) for the prevention of acquisition of urogenital Chlamydia trachomatis infection
Conditions
- Chlamydia Trachomatis Infection
Interventions
EVO100Drug
5 g dose applied up to 1 hour prior to coitus
PlaceboDrug
5 g dose applied up to 1 hour prior to coitus
Primary outcomes
What the sponsor says the trial is designed to measure.
- Urogenital CT InfectionTime frame: 16 weeks
Locations
50 sites in 1 country. Site status is shown where the registry gives one.
Coastal Clinical Research, Inc.
Mobile, Alabama
Mobile OB-GYN, PC
Mobile, Alabama
MedPharmics, LLC
Phoenix, Arizona
Precision Trials AZ, LLC
Phoenix, Arizona
Eclipse Clinical Research
Tucson, Arizona
California Center for Clinical Research
Arcadia, California
Hope Clinical Research
Canoga Park, California
United Clinical Research
Huntington Park, California
Medical Center for Clinical Research - Wake Research
San Diego, California
Optimus Medical Group, Inc.
San Francisco, California
AFC Urgent Care Denver
Denver, Colorado
Planned Parenthood of Southern New England
New Haven, Connecticut
Precision Clinical Research
Lauderdale Lakes, Florida
South Florida Research Center, Inc.
Miami, Florida
Panax Clinical Research
Miami Lakes, Florida
Global Health Research Center
Miami Lakes, Florida
Physician Care Clinical Research LLC
Sarasota, Florida
Comprehensive Clinical Trials, LLC
West Palm Beach, Florida
Columbus Regional Research Institute - IACT Health
Columbus, Georgia
Renew Health Clinical Research, LLC
Lawrenceville, Georgia
Meridian Clinical Research
Richmond Hill, Georgia
ASR, LLC
Nampa, Idaho
John H. Stroger Jr. Hospital of Cook County
Chicago, Illinois
DM Clinical Research
Alexandria, Louisiana
DelRicht Research
New Orleans, Louisiana
Valley OB-GYN
Saginaw, Michigan
MedPharmics, LLD
Biloxi, Mississippi
University of MS Medical Center
Jackson, Mississippi
Nevada Obstetrical Charity Clinic
Las Vegas, Nevada
Bosque Women's Care
Albuquerque, New Mexico
Wake Research Associates, LLC
Raleigh, North Carolina
PMG Research of Salisbury
Salisbury, North Carolina
PMG Research, Inc. - Wilmington Health
Wilmington, North Carolina
University of Cincinnati Physicians
Cincinnati, Ohio
Planned Parenthood Southeastern Pennsylvania
Philadelphia, Pennsylvania
Magee Womens Hospital of UPMC
Pittsburgh, Pennsylvania
Invocare Clinical Research Center
West Columbia, South Carolina
University of Tennessee Medical Center
Knoxville, Tennessee
Adams Patterson OB/GYN, Medical Research Center of Memphis
Memphis, Tennessee
Premier Family Physicians
Austin, Texas
Showing 40 of 50 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.